Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Eikon Therapeutics raises $351M Series D as lead drug starts Phase 3
2 months ago
Startups
En vogue Chinese ADC biotech lets Hong Kong IPO filing lapse
2 months ago
Startups
China
Where the money is: The top 100 venture investors in biotech
2 months ago
Bioregnum
Alcon tried to sink Aurion's IPO in 'Valentine's Day massacre,' new lawsuits say
2 months ago
Cell/Gene Tx
Law
23andMe's CEO submits bid to take company private for $74.7M
2 months ago
Health Tech
Nvidia-backed Achira debuts, blending AI and physics to model molecules
3 months ago
AI
Paris startup collects €27M in Series B to advance overactive bladder treatment
3 months ago
Startups
Exclusive: Lux leads $25M Series A in a Lithuanian startup plotting US expansion
3 months ago
Startups
Exclusive: Atomwise, a once high-flying AI startup, taps biotech vet as CEO to lead pared-down company
3 months ago
People
AI
Pain biotech Latigo eyes up to $150M raise following Vertex's landmark FDA nod
3 months ago
Startups
BioNTech vets raise $90M Series A for bispecific I&I startup
3 months ago
R&D
Hunger-suppressing biotech Aardvark raises $94M in IPO
3 months ago
Startups
After helping build AlphaFold, a 34-year-old first-time CEO launches his own AI biotech with $50M
3 months ago
AI
High medical costs have eaten away at CVS Health's earnings all year. There’s no quick fix
3 months ago
Health Tech
After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmaker
3 months ago
Startups
Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesity
3 months ago
R&D
Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out
3 months ago
People
Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing
3 months ago
Startups
With first drug now in the clinic, Alys eyes megaround for rest of pipeline
3 months ago
Startups
Sionna seeks $135M IPO to fuel tests of cystic fibrosis drug candidates
3 months ago
Startups
Australian biotech AdvanCell nabs $112M Series C for radiopharmaceuticals
3 months ago
Startups
Friday IPO doubleheader from Maze and Metsera brings life to biotech debuts
3 months ago
Startups
Blackstone secures $1.6B so far for new life sciences fund targeted at $5B+
3 months ago
8VC, a tech and life sciences VC firm behind Altos Labs, eyes $1B fund
3 months ago
Startups
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page